HUP9901739A2 - Amino-izokinolin- és amino-tienopiridin-származékok, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények - Google Patents

Amino-izokinolin- és amino-tienopiridin-származékok, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények

Info

Publication number
HUP9901739A2
HUP9901739A2 HU9901739A HUP9901739A HUP9901739A2 HU P9901739 A2 HUP9901739 A2 HU P9901739A2 HU 9901739 A HU9901739 A HU 9901739A HU P9901739 A HUP9901739 A HU P9901739A HU P9901739 A2 HUP9901739 A2 HU P9901739A2
Authority
HU
Hungary
Prior art keywords
alkyl
atom
ring
general formula
phenyl
Prior art date
Application number
HU9901739A
Other languages
English (en)
Inventor
Peter Hamley
James Macdonald
James Matz
Alan Tinker
Original Assignee
Astra Pharmaceuticals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9607717.7A external-priority patent/GB9607717D0/en
Priority claimed from GBGB9608678.0A external-priority patent/GB9608678D0/en
Priority claimed from GBGB9610892.3A external-priority patent/GB9610892D0/en
Application filed by Astra Pharmaceuticals Ltd. filed Critical Astra Pharmaceuticals Ltd.
Publication of HUP9901739A2 publication Critical patent/HUP9901739A2/hu
Publication of HUP9901739A3 publication Critical patent/HUP9901739A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

A találmány tárgyát az (I) általánős képletű vegyületek - ahől R (i) fenil-, benztiazőlil- vagy 1-3 heterőatőmős, hattagú, arőmásheterőciklűs, és a fenilcsőpőrt, a benztiazőlilcsőpőrt benzőgyűrűje ésa heterőciklűsős gyűrű adőtt esetben halőgénatőmmal, alkil-, alkőxi-,alkil-tiő-, hidrőxi- vagy benzil-őxi-csőpőrttal szűbsztitűált, vagy -Q(CH2)pNR4R5 általánős képletű csőpőrt, vagy (ii) adőtt esetben -(CH2)pNR4R5 általánős képletű csőpőrttal szűbsztitűált alkil-,ciklőalkil-, alkinil- vagy piperidilcsőpőrt, vagy -(CH2)pNR4R5általánős képletű csőpőrttal, halőgénatőmmal, alkil-, alkőxi- vagynitrőcsőpőrttal szűbsztitűált fenil-alkil-csőpőrt; vagy (iii) adőttesetben szűbsztitűált, öttagú, heterőciklűsős gyűrű; vagy (iv)hidrőgénatőm vagy fenil-alkinil-csőpőrt; Q őxigénatőm, =NR6 általánős képletű csőpőrt vagy kémiai kötés; R1 hidrőgénatőm, alkil-, alkőxi- vagy trimetil-szilil-csőpőrt, vagyhalőgénatőm; R2 hidrőgénatőm, alkilcsőpőrt, vagy adőtt esetben szűbsztitűáltfenilcsőpőrt; R3 hidrőgén- vagy halőgénatőm; R4, R5 és R6 egymástól függetlenül hidrőgénatőm vagy alkilcsőpőrt,vagy -NR4R5 piperidil-, pirrőlidinil- vagy mőrfőlinilcsőpőrt; p= 1, 2, 3, 4 vagy 5; A tienő- vagy benzőgyűrű; azzal a fenntartással, hőgy ha A benző-gyűrűés Q őxigénatőm, akkőr p 1-től eltérő - vagy gyógyászatilag elfőgadható sóik, enantiőmereikvagy taűtőmereik, az előállításűkra szőlgáló eljárásők, ezekettartalmazó gyógyszerkészítmények. A találmány szerinti vegyületekgyűlladásgátló hatásúak. ŕ
HU9901739A 1996-04-13 1997-04-09 Aminoisoquinolines and aminothienopyridine derivatives, process for producing thereof and pharmaceutical compositions containing them HUP9901739A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9607717.7A GB9607717D0 (en) 1996-04-13 1996-04-13 Pharmaceutically active comounds
GBGB9608678.0A GB9608678D0 (en) 1996-04-26 1996-04-26 Pharmaceuticlly active compounds
GBGB9610892.3A GB9610892D0 (en) 1996-05-24 1996-05-24 Pharmaceutically active compounds

Publications (2)

Publication Number Publication Date
HUP9901739A2 true HUP9901739A2 (hu) 1999-09-28
HUP9901739A3 HUP9901739A3 (en) 2000-06-28

Family

ID=27268241

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9901739A HUP9901739A3 (en) 1996-04-13 1997-04-09 Aminoisoquinolines and aminothienopyridine derivatives, process for producing thereof and pharmaceutical compositions containing them

Country Status (21)

Country Link
US (1) US6063789A (hu)
EP (1) EP0892784A1 (hu)
JP (1) JP2000509028A (hu)
KR (1) KR20000005388A (hu)
CN (1) CN1221407A (hu)
AR (1) AR006619A1 (hu)
AU (1) AU706110B2 (hu)
BR (1) BR9708607A (hu)
CA (1) CA2251681A1 (hu)
CZ (1) CZ327698A3 (hu)
EE (1) EE9800339A (hu)
HU (1) HUP9901739A3 (hu)
ID (1) ID16575A (hu)
IL (1) IL126476A0 (hu)
IS (1) IS4862A (hu)
NO (1) NO984761L (hu)
NZ (1) NZ331932A (hu)
PL (1) PL329308A1 (hu)
SK (1) SK134698A3 (hu)
TR (1) TR199802060T2 (hu)
WO (1) WO1997038977A1 (hu)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999011658A1 (en) 1997-08-29 1999-03-11 Proteus Molecular Design Ltd. Meta-benzamidine derivatives as serin protease inhibitors
WO1999011622A1 (en) * 1997-09-03 1999-03-11 Guilford Pharmaceuticals Inc. Amino-substituted compounds, methods, and compositions for inhibiting parp activity
CA2338304A1 (en) 1998-07-24 2000-02-03 Bayer Aktiengesellschaft Substituted benzoylcyclohexandiones
IT1302677B1 (it) * 1998-10-15 2000-09-29 Zambon Spa Derivati benzazinici inibitori della fosfodiesterasi 4
TW575567B (en) * 1998-10-23 2004-02-11 Akzo Nobel Nv Serine protease inhibitor
SE9901530D0 (sv) * 1999-04-28 1999-04-28 Astra Pharma Prod Novel compounds
DE19920791A1 (de) 1999-05-06 2000-11-09 Bayer Ag Substituierte Benzoylisoxazole
DE19921424A1 (de) 1999-05-08 2000-11-09 Bayer Ag Substituierte Benzoylketone
DE19946853A1 (de) 1999-09-30 2001-04-05 Bayer Ag Substituierte Arylketone
TW591031B (en) * 2000-02-29 2004-06-11 Takeda Chemical Industries Ltd Thienopyridine derivatives, their production and use
US7012098B2 (en) * 2001-03-23 2006-03-14 Pharmacia Corporation Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
CN103936690B (zh) 2005-10-25 2016-06-08 盐野义制药株式会社 氨基二氢噻嗪衍生物
TW200804290A (en) * 2005-11-15 2008-01-16 Astrazeneca Ab Compounds and uses thereof
JP5383483B2 (ja) 2007-04-24 2014-01-08 塩野義製薬株式会社 アルツハイマー症治療用医薬組成物
US8168630B2 (en) 2007-04-24 2012-05-01 Shionogi & Co., Ltd. Aminodihydrothiazine derivatives substituted with a cyclic group
MX2010013256A (es) 2008-06-13 2010-12-21 Shionogi & Co Derivado heterociclico que contiene azufre que tiene actividad inhibitoria de beta-secretasa.
CN102186841A (zh) 2008-10-22 2011-09-14 盐野义制药株式会社 具有bace1抑制活性的2-氨基嘧啶-4-酮及2-氨基吡啶衍生物
WO2011071135A1 (ja) 2009-12-11 2011-06-16 塩野義製薬株式会社 オキサジン誘導体
CN101863900B (zh) * 2010-06-29 2012-07-25 天津药物研究院 一氧化氮供体型噻吩并吡啶衍生物、其制备方法和用途
EP2634186A4 (en) 2010-10-29 2014-03-26 Shionogi & Co naphthyridine
JP5766198B2 (ja) 2010-10-29 2015-08-19 塩野義製薬株式会社 縮合アミノジヒドロピリミジン誘導体
TW201247635A (en) 2011-04-26 2012-12-01 Shionogi & Co Oxazine derivatives and a pharmaceutical composition for inhibiting BAC1 containing them
JP2016501827A (ja) 2012-10-24 2016-01-21 塩野義製薬株式会社 Bace1阻害作用を有するジヒドロオキサジンまたはオキサゼピン誘導体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663550A (en) * 1968-12-25 1972-05-16 Shionogi & Co 2-lower alkyl-2,3-dihydrothieno(3,2-c)quinoline oxides
US3903095A (en) * 1972-02-18 1975-09-02 Merck & Co Inc Certain substituted-thieno{8 3,2-c{9 -pyridines
GB1379111A (en) * 1972-04-13 1975-01-02 Aspro Nicholas Ltd Preparation of fused-ring pyridine and pyrazine derivatives
US4127720A (en) * 1977-09-21 1978-11-28 Bristol-Myers Company Pyrimido[2,1-a]isoquinoline derivatives having antiallergy activity
JPH04348326A (ja) * 1990-07-09 1992-12-03 Sumitomo Electric Ind Ltd 有機非線形光学材料
EP0724570B1 (en) * 1993-10-21 1999-03-03 G.D. Searle & Co. Amidino derivatives useful as nitric oxide synthase inhibitors

Also Published As

Publication number Publication date
KR20000005388A (ko) 2000-01-25
EP0892784A1 (en) 1999-01-27
CZ327698A3 (cs) 1999-05-12
TR199802060T2 (xx) 1999-01-18
IL126476A0 (en) 1999-08-17
SK134698A3 (en) 1999-06-11
NZ331932A (en) 2000-02-28
AR006619A1 (es) 1999-09-08
IS4862A (is) 1998-10-07
ID16575A (id) 1997-10-16
BR9708607A (pt) 1999-08-03
US6063789A (en) 2000-05-16
AU2655097A (en) 1997-11-07
PL329308A1 (en) 1999-03-15
CN1221407A (zh) 1999-06-30
AU706110B2 (en) 1999-06-10
JP2000509028A (ja) 2000-07-18
EE9800339A (et) 1999-04-15
WO1997038977A1 (en) 1997-10-23
HUP9901739A3 (en) 2000-06-28
CA2251681A1 (en) 1997-10-23
NO984761L (no) 1998-12-14
NO984761D0 (no) 1998-10-12

Similar Documents

Publication Publication Date Title
HUP9901739A2 (hu) Amino-izokinolin- és amino-tienopiridin-származékok, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyszerkészítmények
HUP0302962A2 (hu) Béta-karbolinszármazékok, ezeket a vegyületeket tartalmazó gyógyászati készítmények és a vegyületek alkalmazása
HUP9902471A2 (hu) Piperazin- és piperidinvegyületek, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
HUP9802937A2 (hu) Benzo[g]kinolin-származékok, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk
IE792074L (en) Pyran- and thiopyran-fused heterocyclic compounds
GB2023133A (en) Heterocyclic derivatives
NZ212231A (en) Cephalosporin derivatives; intermediates and pharmaceutical compositions
ES8801803A1 (es) Procedimiento para preparar derivados de cinalina.
HUP9801950A2 (hu) 2-(Aril-fenil-amino)-imidazolin-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP9904594A2 (hu) Piperazinoszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
ES455741A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,3-bencenodimetanol.
MX170732B (es) Composicion de derivados de succinimida y su uso
EP0335979A4 (en) Thienopyrimidine derivatives
SE8303913D0 (sv) Heterocykliska foreningar
NZ218404A (en) Cephalosporin derivatives and pharmaceutical compositions
HUP9900883A2 (hu) Helyettesített kinoxalin 2,3-dion származékok aminosav származékai, mint glutamát receptor antagonista vegyületek
IT1216522B (it) Derivati alchiltiobenzimidazolici attivi farmacologicamente eprocedimento per la loro preparazione.
HUP9701479A2 (hu) Hidrolizáló csoportot tartalmazó N-benzil-azolium-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
ES8801205A1 (es) Un procedimiento para la produccion de una isatina y una sal de la misma
GB1454864A (en) Thioureas
ATE18993T1 (de) Dibenzocycloheptenyliden-verbindungen zur verwendung bei der modulation der immunreaktion.
ES476529A1 (es) Procedimiento para la obtencion de derivados de 3-aminopro- poxiarilo.
ATE98961T1 (de) 1,8-benzonaphthyridinderivate und ihre herstellung.
ES556048A0 (es) Un procedimiento para la preparacion de un derivado de tiazolidina.
ES481856A1 (es) Procedimiento para la preparacion de nuevos derivados de 1,3-benzoxacina-2,4-diona con actividad analgesica.